Halozyme Therapeutics, Inc. is a biopharmaceutical company focused on advancing disruptive solutions aimed at improving patient experiences and outcomes for both emerging and established therapies. The company has developed the ENHANZE® drug delivery technology, leveraging the proprietary enzyme rHuPH20 to facilitate the subcutaneous delivery of injected drugs and fluids, enhancing the patient experience with rapid…
Western Maricopa Education Center (WestMEC), a career and technical education school district in Arizona, is one of the first institutions in the United States to incorporate Reax Run and Reax Board into its Physical Therapy program. The Reax Run is a unique treadmill that offers unpredictable tilting to mimic natural running environments, developed to enhance…
Nuvo Group Ltd. (Nuvo), a company known for its pregnancy monitoring device called Invu, has entered into a binding agreement with Nuvo Intl Group Ltd. (Nuvo Intl) amidst a financial restructuring process under Section 363 of the U.S. Bankruptcy Code. Nuvo Intl, funded by Kips Bay Select LP., will acquire substantially all of Nuvos assets,…
OverT Bio, an NYCbased cell therapy company, has been awarded a $120,000 GRex Grant from ScaleReadyTM, in collaboration with Wilson Wolf Manufacturing, BioTechne Corporation (NASDAQ: TECH), and CellReadyTM. This funding will support OverT Bios development of nextgeneration cell therapies for solid tumors, utilizing innovative datadriven discovery platforms OverTargetTM and OverTCRTM. “We are pleased to receive…
Frontline Healthcare Partners (Frontline or FHP), a private equity firm based in Charleston, has announced the final closing of its inaugural fund, Frontline Healthcare Partners, L.P., at $125 million. The Fund is focused on making control investments in microcap distributed healthcare businesses to collaborate with entrepreneurs in creating leading healthcare companies. The Fund leverages Frontline’s…
The Children’s Inn at the National Institutes of Health (NIH) has been awarded a significant $1 million grant from Gilead Sciences Inc. to support its renovation and expansion efforts. This funding will contribute to the creation of The Gilead Sciences Welcome Center, a key part of The Inn of Tomorrow, a substantial $50plus million project…
CV Sciences, Inc., a consumer wellness company specializing in hemp extracts and other sciencebacked natural ingredients, has entered into a definitive agreement to acquire Extract Labs, Inc. Extract Labs is a leading manufacturer and distributor of premium cannabinoid products, including gummies, topicals, and tinctures. The acquisition aims to enhance CV Sciences’ sales to current and…
Pep2Tango Therapeutics Inc. is a biotechnology startup founded in 2021 by experienced pharmaceutical executives. The company is focused on creating innovative, nextgeneration weight loss therapies. Their lead drug candidates are unimolecular multireceptor peptide agonists that target GLP1, GIP, amylin, and calcitonin receptors. This approach aims to provide superior weight loss efficacy while preserving muscle mass…
Debiopharm, a Swissbased global biopharmaceutical company, has received an extension of funding from CARBX, a global nonprofit partnership committed to supporting earlystage antibacterial research and development. The $5.76 million USD grant will aid in the preclinical development of Debio 1453, an innovative antibiotic targeting Neisseria gonorrhoeae infections. The funding is pivotal for the completion of…
TailorMed, a leading innovator in healthcare technology, has announced a $40 million financing round that combines equity and debt. This funding will be used to advance TailorMeds mission of transforming medication access, adherence, and affordability across the United States. The round was led by Windham Capital Partners, with participation from Citi Impact Fund, Samsung Next,…